Seeing Is Believing
Healthcare - Sector
LLY is currently covered by 21 analysts with an average price target of $1238.38. This is a potential upside of $137.72 (4.93%) from yesterday's end of day stock price of $1180.16.
Eli Lilly and Company's activity chart (see below) currently has 609 price targets and 488 ratings on display. The stock rating distribution of LLY is 93.85% BUY, 1.54% SELL and 4.62% HOLD.
Analysts average stock forecasts to be materialized ratio is 89.9% with an average time for these price targets to be met of 251.09 days.
Highest price target for LLY is $1600, Lowest price target is $850, average price target is $1238.38.
Most recent stock forecast was given by ROBYN KARNAUSKAS from TRUIST on 07-Aug-2026. First documented stock forecast 11-Nov-2013.
Currently out of the existing stock ratings of LLY, 61 are a BUY (93.85%), 1 are a SELL (1.54%), 3 are a HOLD (4.62%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Nov-2021
$1376
$195.84 (16.59%)
$1370
Buy Since 14-Apr-2023
$1330
$149.84 (12.70%)
$1280
Buy Since 27-Feb-2020
$1410
$229.84 (19.48%)
$1350
Buy Since 13-Oct-2017
$1600
$419.84 (35.57%)
$1500
Buy Since 12-Dec-2024
$1385
$204.84 (17.36%)
$1100
What is LLY (Eli Lilly and Company) average time for price targets to be met?
Which analyst has the current highest performing score on LLY (Eli Lilly and Company) with a proven track record?
Which analyst has the most public recommendations on LLY (Eli Lilly and Company)?
Which analyst is the currently most bullish on LLY (Eli Lilly and Company)?
Which analyst is the currently most reserved on LLY (Eli Lilly and Company)?